Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00591500 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT00591500 · ClinicalTrials.gov record · last posted 2026-08-05

A Model for Genetic Susceptibility: Melanoma

StatusActive, Not Recruiting
PhaseNot specified
Started1999-11
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The goal of this study is to find out if some people are more likely to get melanoma, a form of skin cancer, than others are. To do this we will compare people who have had more than one melanoma to people who have had only one melanoma and to people who are similar but who have not developed melanoma. People respond to the environment in different ways. Some may be born with genes that make them more likely to get this type of skin cancer. Each person has many ways to repair normal damage to their genes. Specific genes may affect the repair of sun damage. Other genes affect the way the skin itself reacts to the sun. We want to find out which genes have normal changes in them and lead to different responses to exposures, such as the sun. We also want to find out if sun habits are related to the way these genes work.

Protocol amendment history 2 changes detected by DataLookout

2026-08-06
critical
Primary completion pushed: 2026-07 → 2027-07
2026-08-06
minor
Completion pushed: 2026-07 → 2027-07
Trial Details
NCT Number NCT00591500
Lead Sponsor Memorial Sloan Kettering Cancer Center
Collaborators: National Cancer Institute (NCI), University of New Mexico, University of North Carolina, University of Michigan, University of California, Irvine, New South Wales Cancer Control, University of Tasmania, Registro dei Tumori, Torino, Italy, British Columbia Cancer Agency, Cancer Care Ontario, University of Pennsylvania
Conditions Melanoma, Skin Cancer
Enrollment 4,082 participants
Start Date 1999-11
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-05